WASHINGTON (AP) — Threatening fines and funding cut-offs, the Trump administration issued new COVID-19 requirements for nursing homes and hospitals, prompting immediate pushback from beleaguered industries.

To check the spread of the coronavirus in nursing homes, the Centers for Medicare and Medicaid Services announced it will require facilities to test staff regularly or face fines.

<a href="https://apnews.com/681479be1d9f1a0fea4d64b1a44d5b9e">The move comes months after the White House</a>&nbsp;first urged governors to test all nursing home residents and staff. With residents, nursing homes are being required to offer them coronavirus tests if there is an outbreak or if any show symptoms.

Officials also reinforced a reporting mandate for hospitals. It included a thinly veiled threat to cut off Medicare and Medicaid funds to facilities that fail to report certain COVID-19 data daily to the federal Health and Human Services department. Hospitals responded with a sharp rebuke, calling the move “heavy-handed” and raising the specter of loss of vital services for local communities in a pandemic, less than three months before Election Day.

Long-term care facilities represent less than 1% of the U.S. population, but they account for 42% of the COVID-19 deaths, with more than 70,000 fatalities reported by the COVID Tracking Project.

The plight of frail elders in nursing homes is politically sensitive for President Donald Trump, who is trying to maintain support from older voters amid disapproval of the government’s pandemic response. His administration is distributing fast-test machines to nursing homes, but there are continued reports that&nbsp;<a href="https://apnews.com/ae2b6d71bdc3a9391ae02910d8f0491f">cases have been rising</a>&nbsp;and facilities still face&nbsp;<a href="https://apnews.com/ff2bbfb4a7431e86cdca5132042d4a0e">shortages of supplies</a>&nbsp;like masks.

“Our recommendations for testing in nursing homes go back as far back as March and April,” said Seema Verma, head of the Centers for Medicare and Medicaid Services, or CMS. “What’s different about today is that this is now a requirement ... we want to make sure every single nursing home is complying.”

Independent research indicates that the coronavirus most likely gets into nursing homes via staffers who unwittingly bring it in from surrounding communities where it has started to spread. Staffers who have yet to develop symptoms may have no clue that they’re infected.

Verma said the testing requirement for staff will be keyed to the level of virus activity in local areas. If the positive rate is below 5%, nursing homes will have to test staff once a month. If the rate is 5% - 10%, testing will be required once a week. If the rate is above 10%, staff will have to be tested twice a week. Florida, Iowa and Nevada are examples of states where the COVID-19 positive rate is now above 10%.

The government will provide $2.5 billion to help nursing homes with testing costs, Verma also announced. The administration’s campaign to distribute fast-test machines and an initial supply of tests is supposed to be done by the end of September.

The nursing home industry said it supports mandatory testing as long as facilities are given what they need to comply with requirements.

Mark Parkinson, head of the industry group American Health Care Association, said nursing homes in many parts of the country still can’t get timely results on COVID-19 tests.

CMS “must factor in the delays that continue to be a reality,” Parkinson said in a statement. “Otherwise facilities could face fines for circumstances beyond their control and be conducting tests that are so delayed that they have little clinical value.”

The hospital reporting requirement that was also announced Tuesday follows confusion and misgivings surrounding a Trump administration directive that facilities send critical COVID-19 data directly to HHS instead of the Centers for Disease Control and Prevention, as had been the case.

The information includes numbers of confirmed or suspected COVID-19 cases, how many intensive-care beds are occupied, and the availability of essential supplies and equipment such as ventilators and masks and gowns.

The regulation basically says if hospitals want to continue to participate in Medicare and Medicaid, they must report the information as required. The American Hospital Association called for the requirement to be immediately rescinded.

“Hospitals and health systems consistently have put forward a good faith effort to report the data needed to battle COVID-19 under very trying circumstances, despite the ever-changing requests from the government on data reporting,” Rick Pollack, president of the American Hospital Association, said in a statement. “Since February, the government has made at least six changes to how they want hospitals to report data.”

Federal statistics show that 94% of hospitals are reporting the required data, said Pollack. He added his organization has done some investigation of its own and found that in some cases hospitals had sent in their reports, but the information had not gotten through the government system.

“It’s beyond perplexing why CMS would use a regulatory sledgehammer — threatening Medicare participation — to the very organizations that are on the front lines in the fight against COVID-19.”

CMS chief Verma said the requirement is meant to correct deficiencies in reporting vital data needed to track and contain the pandemic.

WASHINGTON (AP) — Threatening fines and funding cut-offs, the Trump administration issued new COVID-19 requirements for nursing homes and hospitals, prompting immediate pushback from beleaguered industries.To check the spread of the coronavirus in nursing homes, the Centers for Medicare and Medicaid Services announced it will require facilities to test staff regularly or face fines.<a href="https://apnews.com/681479be1d9f1a0fea4d64b1a44d5b9e">The move comes months after the White House</a>&nbsp;first urged governors to test all nursing home residents and staff. With residents, nursing homes are being required to offer them coronavirus tests if there is an outbreak or if any show symptoms.Officials also reinforced a reporting mandate for hospitals. It included a thinly veiled threat to cut off Medicare and Medicaid funds to facilities that fail to report certain COVID-19 data daily to the federal Health and Human Services department. Hospitals responded with a sharp rebuke, calling the move “heavy-handed” and raising the specter of loss of vital services for local communities in a pandemic, less than three months before Election Day.Long-term care facilities represent less than 1% of the U.S. population, but they account for 42% of the COVID-19 deaths, with more than 70,000 fatalities reported by the COVID Tracking Project.The plight of frail elders in nursing homes is politically sensitive for President Donald Trump, who is trying to maintain support from older voters amid disapproval of the government’s pandemic response. His administration is distributing fast-test machines to nursing homes, but there are continued reports that&nbsp;<a href="https://apnews.com/ae2b6d71bdc3a9391ae02910d8f0491f">cases have been rising</a>&nbsp;and facilities still face&nbsp;<a href="https://apnews.com/ff2bbfb4a7431e86cdca5132042d4a0e">shortages of supplies</a>&nbsp;like masks.“Our recommendations for testing in nursing homes go back as far back as March and April,” said Seema Verma, head of the Centers for Medicare and Medicaid Services, or CMS. “What’s different about today is that this is now a requirement ... we want to make sure every single nursing home is complying.”Independent research indicates that the coronavirus most likely gets into nursing homes via staffers who unwittingly bring it in from surrounding communities where it has started to spread. Staffers who have yet to develop symptoms may have no clue that they’re infected.Verma said the testing requirement for staff will be keyed to the level of virus activity in local areas. If the positive rate is below 5%, nursing homes will have to test staff once a month. If the rate is 5% - 10%, testing will be required once a week. If the rate is above 10%, staff will have to be tested twice a week. Florida, Iowa and Nevada are examples of states where the COVID-19 positive rate is now above 10%.The government will provide $2.5 billion to help nursing homes with testing costs, Verma also announced. The administration’s campaign to distribute fast-test machines and an initial supply of tests is supposed to be done by the end of September.The nursing home industry said it supports mandatory testing as long as facilities are given what they need to comply with requirements.Mark Parkinson, head of the industry group American Health Care Association, said nursing homes in many parts of the country still can’t get timely results on COVID-19 tests.CMS “must factor in the delays that continue to be a reality,” Parkinson said in a statement. “Otherwise facilities could face fines for circumstances beyond their control and be conducting tests that are so delayed that they have little clinical value.”The hospital reporting requirement that was also announced Tuesday follows confusion and misgivings surrounding a Trump administration directive that facilities send critical COVID-19 data directly to HHS instead of the Centers for Disease Control and Prevention, as had been the case.The information includes numbers of confirmed or suspected COVID-19 cases, how many intensive-care beds are occupied, and the availability of essential supplies and equipment such as ventilators and masks and gowns.The regulation basically says if hospitals want to continue to participate in Medicare and Medicaid, they must report the information as required. The American Hospital Association called for the requirement to be immediately rescinded.“Hospitals and health systems consistently have put forward a good faith effort to report the data needed to battle COVID-19 under very trying circumstances, despite the ever-changing requests from the government on data reporting,” Rick Pollack, president of the American Hospital Association, said in a statement. “Since February, the government has made at least six changes to how they want hospitals to report data.”Federal statistics show that 94% of hospitals are reporting the required data, said Pollack. He added his organization has done some investigation of its own and found that in some cases hospitals had sent in their reports, but the information had not gotten through the government system.“It’s beyond perplexing why CMS would use a regulatory sledgehammer — threatening Medicare participation — to the very organizations that are on the front lines in the fight against COVID-19.”CMS chief Verma said the requirement is meant to correct deficiencies in reporting vital data needed to track and contain the pandemic.

New COVID-19 mandates on health care facilities get pushback

LONDON&nbsp; (AP)— The World Health Organization says countries should actively test people to find coronavirus cases, even if they have mild or no symptoms.

That’s despite the U.S. Centers for Disease Control and Prevention’s recently switched guidance to say asymptomatic contacts of cases don’t need to be tested.

Maria Van Kerkhove, WHO’s technical lead for the coronavirus, says when officials are investigating clusters of COVID-19, “testing may need to be expanded to look for individuals who are on the more mild end of the spectrum or who may indeed be asymptomatic.”

Van Kerkhove says countries were free to adapt their testing guidance for their individual needs and its critical how fast countries get results.

“What’s really important is that testing is used as an opportunity, to define active cases so that they can be isolated and so that contact tracing can also take place,” Van Kerkhove said. “This is really fundamental to breaking chains of transmission.”

Earlier in the pandemic, WHO recommend that countries focus on “testing, testing, testing.”

Van Kerkhove also says wearing masks alone to protect against the spread of the coronavirus isn’t enough, expressing concerns that people are growing too lax on maintaining physical distancing.

“So it’s not just masks alone. It’s not just physical distancing alone,” Van Kerkhove said. “It’s not just hand cleaning alone. Do it all.”

LONDON&nbsp; (AP)— The World Health Organization says countries should actively test people to find coronavirus cases, even if they have mild or no symptoms.That’s despite the U.S. Centers for Disease Control and Prevention’s recently switched guidance to say asymptomatic contacts of cases don’t need to be tested.Maria Van Kerkhove, WHO’s technical lead for the coronavirus, says when officials are investigating clusters of COVID-19, “testing may need to be expanded to look for individuals who are on the more mild end of the spectrum or who may indeed be asymptomatic.”Van Kerkhove says countries were free to adapt their testing guidance for their individual needs and its critical how fast countries get results.“What’s really important is that testing is used as an opportunity, to define active cases so that they can be isolated and so that contact tracing can also take place,” Van Kerkhove said. “This is really fundamental to breaking chains of transmission.”Earlier in the pandemic, WHO recommend that countries focus on “testing, testing, testing.”Van Kerkhove also says wearing masks alone to protect against the spread of the coronavirus isn’t enough, expressing concerns that people are growing too lax on maintaining physical distancing.“So it’s not just masks alone. It’s not just physical distancing alone,” Van Kerkhove said. “It’s not just hand cleaning alone. Do it all.”

WHO says test for virus, despite CDC's recent flip flop

TOPEKA —Gov. Laura Kelly announced a new program Thursday to help essential workers sickened with coronavirus cover the cost of medical care. The program, which will be paid for with $8 million in federal COVID-19 relief funds, will provide workers in fields such as child care, education and food service up to $25,000 for medical expenses if they are uninsured and $15,000 if they are insured and need help with copays and deductibles.

Before, they were out of luck, trial attorneys and some legislators say. They say the issue is that Kansas law is written so that coronavirus is almost certainly not an occupational disease, which means if you get it on the job, you can’t get benefits through that system. But, because the law says the workers’ compensation system is the exclusive remedy for on-the-job injuries and occupational diseases, you can’t sue your employer, either.

“The dedication and selflessness displayed by Kansas essential workers has been critical to our recovery efforts across the state in cities big and small and rural communities,” Kelly said in a news release. 

“They risk their health each and every day to help others and these funds make it possible for the state of Kansas to help cover expenses in the unfortunate cases when they contract COVID-19.”

<figure>
 <img src="https://media.eaglewebservices.com/public/2020/3/1584111668151.png" alt="" />
 <figcaption></figcaption>
 </figure>TOPEKA —Gov. Laura Kelly announced a new program Thursday to help essential workers sickened with coronavirus cover the cost of medical care. The program, which will be paid for with $8 million in federal COVID-19 relief funds, will provide workers in fields such as child care, education and food service up to $25,000 for medical expenses if they are uninsured and $15,000 if they are insured and need help with copays and deductibles.Before, they were out of luck, trial attorneys and some legislators say. They say the issue is that Kansas law is written so that coronavirus is almost certainly not an occupational disease, which means if you get it on the job, you can’t get benefits through that system. But, because the law says the workers’ compensation system is the exclusive remedy for on-the-job injuries and occupational diseases, you can’t sue your employer, either.“The dedication and selflessness displayed by Kansas essential workers has been critical to our recovery efforts across the state in cities big and small and rural communities,” Kelly said in a news release. “They risk their health each and every day to help others and these funds make it possible for the state of Kansas to help cover expenses in the unfortunate cases when they contract COVID-19.”

Kansas creates COVID-19 essential worker health care fund

NEW YORK (AP) — U.S. health officials sparked criticism and confusion after posting guidelines on coronavirus testing from the White House task force that run counter to what scientists say is necessary to control the pandemic.

The new guidance says it’s not necessary for people who have been in close contact with infected people, but don’t feel sick, to get tested. It was posted earlier this week on the website of the Centers for Disease Control and Prevention.

The CDC previously had advised local health departments to test people who have been within 6 feet of an infected person for more than 15 minutes.

Across the country, public health experts called the change bizarre. They noted that testing contacts of infected people is a core element of public health efforts to keep outbreaks in check, and that a large percentage of infected people — the CDC has said as many as 40% — exhibit no symptoms.

“The recommendation not to test asymptomatic people who likely have been exposed is not in accord with the science,” said John Auerbach, president of Trust for America’s Health, a nonprofit that works to improve U.S. preparedness against disease.

“We are seeking clarification from CDC about its recent guidance around testing,” said a spokesman for Michigan’s health department.

Federal officials said the new recommendation was issued by consensus of the White House virus task force.

However, Dr. Anthony Fauci, the country’s top infectious disease expert and perhaps the best known task force member, said Wednesday he wasn’t part of the discussion that green-lighted the change.

Fauci told CNN he was undergoing surgery when the new guidance was discussed last week, adding he was “worried it will give people the incorrect assumption that asymptomatic spread is not of great concern. In fact it is.”

The American Medical Association, in a statement, called the change “a recipe for community spread.” The Association of American Medical Colleges called it “a step backward in fighting the pandemic.”

Some officials — including some state governors — said it was another sign of a dysfunctional federal response to the pandemic.

“This is like a public health version of Vietnam,” said Brian Castrucci, president and CEO of the de Beaumont Foundation, which works to strengthen the public health system.

CDC officials referred all media questions to the agency’s parent organization, the U.S. Department of Health and Human Services in Washington, D.C. That suggests that HHS ordered the change, not CDC, said Jennifer Nuzzo, a Johns Hopkins University public health researcher.

After Twitter lit up with head-scratching and alarm about the change, HHS officials sent an email Wednesday saying the guidance was revised “to reflect current evidence and the best public health interventions,” but did not detail what the new evidence was.

The decision came out of meetings of the White House coronavirus task force, HHS officials said.

In a call with reporters, Dr. Brett Giroir, the HHS assistant secretary for health, said guidance language originated at the CDC. But he also said many federal leaders outside the agency were involved in “lots of editing, lots of input.” He said federal officials achieved consensus but it was difficult to attribute the final language to any one source.

Ultimately, restricting testing could be self-defeating, because it could skew the numbers and create a perception that rates of infection are higher. Testing people who appear to be healthy would tend to lower the overall rate of positive results, while narrowing testing to people who are sick would raise the overall positive rate, Auerbach said.

Why HHS would order such a change quickly became a matter of speculation. Dr. Carlos del Rio, an infectious diseases specialist at Emory University, suggested in a tweet that there are two possible explanations.

One is that it may be driven by testing supply issues that in many parts of the country have caused widely reported delays in results of a week or more, he suggested.

HHS officials suggested that wasn’t the reason, arguing that testing capacity is plentiful.

But Dr. Mysheika Roberts, health commissioner for Columbus, Ohio, said the city had to curtail testing last month because of a shortage of reagents used in lab procedures.

“When we were testing asymptomatic people here in Columbus, we were picking up a large number of individuals” with the virus, she said

Another possible explanation for the change is that President Donald Trump simply wants to see case counts drop, and discouraging more people from getting tested is one way to do it, del Rio said in his tweet.

Full Coverage:&nbsp;<a href="https://apnews.com/tag/VirusOutbreak">Virus Outbreak</a>

Giroir said the change was made without input from Trump or Vice President Mike Pence. “There was no weight on the scales by the president or the vice president” or HHS Secretary Alex Azar, Giroir said.

Dr. Tom Frieden, who was head of the CDC during the Obama administration, said the move follows another recent change: to no longer recommend quarantine for travelers coming from areas where infections are more common.

“Both changes are highly problematic” and need to be better explained, said Frieden, who now is president of Resolve to Save Lives, a nonprofit program that works to prevent epidemics.

Frieden said he, too, believes HHS forced CDC to post the changes. He called it “a sad day” because “CDC is being told what to write on their website.”

The governors of California, New York, Washington and Kentucky — all Democrats — criticized the new recommendations.

Washington Gov Jay Inslee said on Twitter that the changes likely will cause thousands of infections in his state to go unrecognized, and allow the virus to spread even more. Kentucky Gov. Andy Beshear called the new guidance “reckless.”

California Gov. Gavin Newsom and New York Gov. Andrew Cuomo said their states will not follow the new guidance.

“We will not be influenced by that change,” Newsom said. “We’re influenced by the folks that are experts in the field who feel very differently.”

“Why would you reverse yourself on the quarantine order?” Cuomo told reporters on a conference call. “Because they don’t want publicity that there is a COVID problem. Because the president’s politics are, ‘COVID isn’t a problem We’re past COVID.’”

NEW YORK (AP) — U.S. health officials sparked criticism and confusion after posting guidelines on coronavirus testing from the White House task force that run counter to what scientists say is necessary to control the pandemic.The new guidance says it’s not necessary for people who have been in close contact with infected people, but don’t feel sick, to get tested. It was posted earlier this week on the website of the Centers for Disease Control and Prevention.The CDC previously had advised local health departments to test people who have been within 6 feet of an infected person for more than 15 minutes.Across the country, public health experts called the change bizarre. They noted that testing contacts of infected people is a core element of public health efforts to keep outbreaks in check, and that a large percentage of infected people — the CDC has said as many as 40% — exhibit no symptoms.“The recommendation not to test asymptomatic people who likely have been exposed is not in accord with the science,” said John Auerbach, president of Trust for America’s Health, a nonprofit that works to improve U.S. preparedness against disease.“We are seeking clarification from CDC about its recent guidance around testing,” said a spokesman for Michigan’s health department.Federal officials said the new recommendation was issued by consensus of the White House virus task force.However, Dr. Anthony Fauci, the country’s top infectious disease expert and perhaps the best known task force member, said Wednesday he wasn’t part of the discussion that green-lighted the change.Fauci told CNN he was undergoing surgery when the new guidance was discussed last week, adding he was “worried it will give people the incorrect assumption that asymptomatic spread is not of great concern. In fact it is.”The American Medical Association, in a statement, called the change “a recipe for community spread.” The Association of American Medical Colleges called it “a step backward in fighting the pandemic.”Some officials — including some state governors — said it was another sign of a dysfunctional federal response to the pandemic.“This is like a public health version of Vietnam,” said Brian Castrucci, president and CEO of the de Beaumont Foundation, which works to strengthen the public health system.CDC officials referred all media questions to the agency’s parent organization, the U.S. Department of Health and Human Services in Washington, D.C. That suggests that HHS ordered the change, not CDC, said Jennifer Nuzzo, a Johns Hopkins University public health researcher.After Twitter lit up with head-scratching and alarm about the change, HHS officials sent an email Wednesday saying the guidance was revised “to reflect current evidence and the best public health interventions,” but did not detail what the new evidence was.The decision came out of meetings of the White House coronavirus task force, HHS officials said.In a call with reporters, Dr. Brett Giroir, the HHS assistant secretary for health, said guidance language originated at the CDC. But he also said many federal leaders outside the agency were involved in “lots of editing, lots of input.” He said federal officials achieved consensus but it was difficult to attribute the final language to any one source.Ultimately, restricting testing could be self-defeating, because it could skew the numbers and create a perception that rates of infection are higher. Testing people who appear to be healthy would tend to lower the overall rate of positive results, while narrowing testing to people who are sick would raise the overall positive rate, Auerbach said.Why HHS would order such a change quickly became a matter of speculation. Dr. Carlos del Rio, an infectious diseases specialist at Emory University, suggested in a tweet that there are two possible explanations.One is that it may be driven by testing supply issues that in many parts of the country have caused widely reported delays in results of a week or more, he suggested.HHS officials suggested that wasn’t the reason, arguing that testing capacity is plentiful.But Dr. Mysheika Roberts, health commissioner for Columbus, Ohio, said the city had to curtail testing last month because of a shortage of reagents used in lab procedures.“When we were testing asymptomatic people here in Columbus, we were picking up a large number of individuals” with the virus, she saidAnother possible explanation for the change is that President Donald Trump simply wants to see case counts drop, and discouraging more people from getting tested is one way to do it, del Rio said in his tweet.Full Coverage:&nbsp;<a href="https://apnews.com/tag/VirusOutbreak">Virus Outbreak</a>Giroir said the change was made without input from Trump or Vice President Mike Pence. “There was no weight on the scales by the president or the vice president” or HHS Secretary Alex Azar, Giroir said.Dr. Tom Frieden, who was head of the CDC during the Obama administration, said the move follows another recent change: to no longer recommend quarantine for travelers coming from areas where infections are more common.“Both changes are highly problematic” and need to be better explained, said Frieden, who now is president of Resolve to Save Lives, a nonprofit program that works to prevent epidemics.Frieden said he, too, believes HHS forced CDC to post the changes. He called it “a sad day” because “CDC is being told what to write on their website.”The governors of California, New York, Washington and Kentucky — all Democrats — criticized the new recommendations.Washington Gov Jay Inslee said on Twitter that the changes likely will cause thousands of infections in his state to go unrecognized, and allow the virus to spread even more. Kentucky Gov. Andy Beshear called the new guidance “reckless.”California Gov. Gavin Newsom and New York Gov. Andrew Cuomo said their states will not follow the new guidance.“We will not be influenced by that change,” Newsom said. “We’re influenced by the folks that are experts in the field who feel very differently.”“Why would you reverse yourself on the quarantine order?” Cuomo told reporters on a conference call. “Because they don’t want publicity that there is a COVID problem. Because the president’s politics are, ‘COVID isn’t a problem We’re past COVID.’”___

Officials change COVID testing advice, bewildering experts

Barton County coronavirus update: 74 active cases, 507 quarantines

NEW YORK (AP) — The number of Americans newly diagnosed with the coronavirus is falling — a development experts say most likely reflects more mask-wearing but also insufficient testing — even as the disease continues to claim nearly 1,000 lives in the U.S. each day.

About 43,000 new cases are being reported daily across the country, down 21% from early August, according to data compiled by Johns Hopkins University. While the U.S., India and Brazil still have the highest numbers of new cases in the world, the downward trend is encouraging.

“It’s profoundly hopeful news,” said Dr. Monica Gandhi, an infectious-diseases expert at the University of California, San Francisco, who credits the American public’s growing understanding of how the virus spreads, more mask-wearing and, possibly, an increasing level of immunity.

“Hopefully all those factors are coming into play to get this virus under control in this country that’s really been battered by the pandemic,” she said.

But insufficient testing is probably concealing the full extent of the crisis, said Dr. Jonathan Quick, who leads the pandemic response for the Rockefeller Foundation, which has recommended the U.S. test 4 million people a day by fall.

“We’re grossly under-testing in some of the places that are still having high caseloads,” Quick said, singling out Mississippi, Texas, Georgia and North Dakota as hot spots with high rates of positive test results.

Even at 43,000 new cases per day, the U.S. remains far above the numbers seen during the spring, when new daily cases peaked at about 34,000, he said.

“It’s a good trend, but nowhere near what we need to be,” Quick said of the recent decline.

The virus is blamed for more than 5.7 million confirmed infections and about 178,000 deaths in the U.S. Worldwide, the death toll is put at more than 810,000, with about 23.7 million cases.

Jeffrey Shaman, a public health expert at Columbia University, said he is skeptical enough people are immune to significantly slow the spread. But he agreed that changes in Americans’ behavior could well be making a difference, recalling the impact that people’s actions had in containing Ebola in West Africa several years ago.

“Ebola stopped for reasons we didn’t anticipate at the time. It was so horrifying that people stopped touching each other,” Shaman said. Something similar may be happening with the coronavirus, he said.

“I know I don’t have nearly the number of contacts that I used to,” Shaman said. “But if we relax that, if we get complacent, will we just see another outbreak?”

The decline in newly reported cases in the U.S. comes even as deaths from the virus remain alarmingly high. Over the past two weeks, officials have reported an average of 965 deaths a day from COVID-19, down from 1,051 a day in early August.

Deaths from the coronavirus are a lagging indicator — they trail new infections because of the time it takes for people to get sick and succumb to the disease.

The percentage of tests coming back positive for the disease has also declined over the past two weeks, from 7.3% to 6.1%. But that comes as the total number of tests administered has fallen from its August peak of more than 820,000 a day, leveling off in recent weeks at about 690,000 a day.

The situation has improved dramatically in several states that struggled with high caseloads earlier this summer.

In Arizona, for example, officials reported 859 new cases Tuesday, down from a peak of 5,500 in late June. More than 2,000 people arrived at the state’s hospitals showing symptoms of the virus on a single day in early July. This week, that number has been less than 1,000.

In Florida, where more than 10,000 people have died, the state reported 2,600 new virus cases Tuesday. Earlier in the summer, it was regularly reporting more than 10,000 new cases.

Malinda Coler, 37, of San Francisco, said she has been diligent about mask wearing and other preventive measures, less to protect herself than a best friend who has a compromised immune system, with severe arthritis psoriasis.

“So I wear a damned mask and get infuriated when others don’t,” she said.

Most states now have some type of mask requirement, either through statewide orders issued by governors or from city and county rules that cover most of their population.

Even some conservative governors have gone along with masks. Mississippi Gov. Tate Reeves mandated masks in all public places earlier this month, and Georgia Gov. Brian Kemp dropped a lawsuit against Atlanta in a dispute over a requirement by the state’s largest city.

In Leeds, Alabama, Will Heath said he has seen greater adherence to mask rules around town, whether in stores or at his 5-year-old daughter’s cheerleading practice.

He and his wife, a nurse, have worn masks all along but said the attitude among others has shifted from “Even if I get it, I’ll be OK,” to “Let’s make sure we don’t give it to somebody else.”

“We have all been sort of operating under the assumption that we all have it or we’re going to get it eventually. So we want to make sure we don’t spread it,” Heath said.

Many places around the U.S. are seeing pockets of contagion, especially in college towns where students are holding parties and crowding into bars.

Over the past week, 531 students, faculty and staff at the University of Alabama in Tuscaloosa have tested positive for the virus, according to the school. Alabama said it tested nearly 30,000 students before classes began. The mayor of Tuscaloosa shut down bars for two weeks because of the spike, which could derail plans to continue the semester on campus.

The university is still moving ahead with fall sports in the football-crazed state, with plans to allow only about 20,000 fans at its 101,000-capacity stadium and a ban on tailgating. Coach Nick Saban weighed in on the virus Monday, urging people to wear masks.

“It’s not just about football. So, for people to make the right choices and decisions to wear their masks, do the things when they’re out publicly, respect the rules, respect the virus, that’s important,” he said.

It’s not clear what will happen to case numbers as more school districts bring students back to classrooms and colleges reopen their campuses. In recent weeks, schools including the University of North Carolina, Michigan State and Notre Dame have moved instruction online after outbreaks on their campuses.

Officials at the University of Tennessee at Knoxville said four students are facing disciplinary proceedings after three hosted off-campus parties with no mask or other distancing and another left isolation to meet with others despite testing positive for the virus.

“If the facts reported to the university are accurate, these students will face at least suspension from the university, and potentially greater penalties,” Chancellor Donde Plowman wrote.

<figure>
 <img src="https://media.eaglewebservices.com/public/2020/5/1590784947764.jpeg" alt="" />
 <figcaption></figcaption>
 </figure>NEW YORK (AP) — The number of Americans newly diagnosed with the coronavirus is falling — a development experts say most likely reflects more mask-wearing but also insufficient testing — even as the disease continues to claim nearly 1,000 lives in the U.S. each day.About 43,000 new cases are being reported daily across the country, down 21% from early August, according to data compiled by Johns Hopkins University. While the U.S., India and Brazil still have the highest numbers of new cases in the world, the downward trend is encouraging.“It’s profoundly hopeful news,” said Dr. Monica Gandhi, an infectious-diseases expert at the University of California, San Francisco, who credits the American public’s growing understanding of how the virus spreads, more mask-wearing and, possibly, an increasing level of immunity.“Hopefully all those factors are coming into play to get this virus under control in this country that’s really been battered by the pandemic,” she said.But insufficient testing is probably concealing the full extent of the crisis, said Dr. Jonathan Quick, who leads the pandemic response for the Rockefeller Foundation, which has recommended the U.S. test 4 million people a day by fall.“We’re grossly under-testing in some of the places that are still having high caseloads,” Quick said, singling out Mississippi, Texas, Georgia and North Dakota as hot spots with high rates of positive test results.Even at 43,000 new cases per day, the U.S. remains far above the numbers seen during the spring, when new daily cases peaked at about 34,000, he said.“It’s a good trend, but nowhere near what we need to be,” Quick said of the recent decline.The virus is blamed for more than 5.7 million confirmed infections and about 178,000 deaths in the U.S. Worldwide, the death toll is put at more than 810,000, with about 23.7 million cases.Jeffrey Shaman, a public health expert at Columbia University, said he is skeptical enough people are immune to significantly slow the spread. But he agreed that changes in Americans’ behavior could well be making a difference, recalling the impact that people’s actions had in containing Ebola in West Africa several years ago.“Ebola stopped for reasons we didn’t anticipate at the time. It was so horrifying that people stopped touching each other,” Shaman said. Something similar may be happening with the coronavirus, he said.“I know I don’t have nearly the number of contacts that I used to,” Shaman said. “But if we relax that, if we get complacent, will we just see another outbreak?”The decline in newly reported cases in the U.S. comes even as deaths from the virus remain alarmingly high. Over the past two weeks, officials have reported an average of 965 deaths a day from COVID-19, down from 1,051 a day in early August.Deaths from the coronavirus are a lagging indicator — they trail new infections because of the time it takes for people to get sick and succumb to the disease.The percentage of tests coming back positive for the disease has also declined over the past two weeks, from 7.3% to 6.1%. But that comes as the total number of tests administered has fallen from its August peak of more than 820,000 a day, leveling off in recent weeks at about 690,000 a day.The situation has improved dramatically in several states that struggled with high caseloads earlier this summer.In Arizona, for example, officials reported 859 new cases Tuesday, down from a peak of 5,500 in late June. More than 2,000 people arrived at the state’s hospitals showing symptoms of the virus on a single day in early July. This week, that number has been less than 1,000.In Florida, where more than 10,000 people have died, the state reported 2,600 new virus cases Tuesday. Earlier in the summer, it was regularly reporting more than 10,000 new cases.Malinda Coler, 37, of San Francisco, said she has been diligent about mask wearing and other preventive measures, less to protect herself than a best friend who has a compromised immune system, with severe arthritis psoriasis.“So I wear a damned mask and get infuriated when others don’t,” she said.Most states now have some type of mask requirement, either through statewide orders issued by governors or from city and county rules that cover most of their population.Even some conservative governors have gone along with masks. Mississippi Gov. Tate Reeves mandated masks in all public places earlier this month, and Georgia Gov. Brian Kemp dropped a lawsuit against Atlanta in a dispute over a requirement by the state’s largest city.In Leeds, Alabama, Will Heath said he has seen greater adherence to mask rules around town, whether in stores or at his 5-year-old daughter’s cheerleading practice.He and his wife, a nurse, have worn masks all along but said the attitude among others has shifted from “Even if I get it, I’ll be OK,” to “Let’s make sure we don’t give it to somebody else.”“We have all been sort of operating under the assumption that we all have it or we’re going to get it eventually. So we want to make sure we don’t spread it,” Heath said.Many places around the U.S. are seeing pockets of contagion, especially in college towns where students are holding parties and crowding into bars.Over the past week, 531 students, faculty and staff at the University of Alabama in Tuscaloosa have tested positive for the virus, according to the school. Alabama said it tested nearly 30,000 students before classes began. The mayor of Tuscaloosa shut down bars for two weeks because of the spike, which could derail plans to continue the semester on campus.The university is still moving ahead with fall sports in the football-crazed state, with plans to allow only about 20,000 fans at its 101,000-capacity stadium and a ban on tailgating. Coach Nick Saban weighed in on the virus Monday, urging people to wear masks.“It’s not just about football. So, for people to make the right choices and decisions to wear their masks, do the things when they’re out publicly, respect the rules, respect the virus, that’s important,” he said.It’s not clear what will happen to case numbers as more school districts bring students back to classrooms and colleges reopen their campuses. In recent weeks, schools including the University of North Carolina, Michigan State and Notre Dame have moved instruction online after outbreaks on their campuses.Officials at the University of Tennessee at Knoxville said four students are facing disciplinary proceedings after three hosted off-campus parties with no mask or other distancing and another left isolation to meet with others despite testing positive for the virus.“If the facts reported to the university are accurate, these students will face at least suspension from the university, and potentially greater penalties,” Chancellor Donde Plowman wrote.___

New virus cases decline in the US and experts credit masks

TOPEKA –&nbsp;Governor Laura Kelly will hold a press conference at 4 p.m. Monday to give an update regarding COVID-19 in Kansas.

Another weekend surge pushed the total number of virus cases for the pandemic past 38,000. The state Department of Health and Environment said Monday that Kansas saw another 1,545 confirmed and probable cases since Friday, an increase of 4.2%. The total since the pandemic began is 38,401.

The health department said all 105 of the state’s counties have had a confirmed or probable case. Rawlins and Wallace counties in western Kansas had remained the only two without a reported case for more than a month before the department said Monday that they had one case each.

TOPEKA –&nbsp;Governor Laura Kelly will hold a press conference at 4 p.m. Monday to give an update regarding COVID-19 in Kansas.<div><iframe src="https://www.facebook.com/plugins/video.php?href=https%3A%2F%2Fwww.facebook.com%2FGovLauraKelly%2Fvideos%2F326252398816890%2F&show_text=0&width=560" width="560" height="315" style="border:none;overflow:hidden" scrolling="no" frameborder="0" allowTransparency="true" allowFullScreen="true"></iframe></div>Another weekend surge pushed the total number of virus cases for the pandemic past 38,000. The state Department of Health and Environment said Monday that Kansas saw another 1,545 confirmed and probable cases since Friday, an increase of 4.2%. The total since the pandemic began is 38,401.<figure>
 <img src="https://media.eaglewebservices.com/public/2020/8/1598288743755.png" alt="August 24, 2020 KDHE image" />
 <figcaption>August 24, 2020 KDHE image</figcaption>
 </figure>The health department said all 105 of the state’s counties have had a confirmed or probable case. Rawlins and Wallace counties in western Kansas had remained the only two without a reported case for more than a month before the department said Monday that they had one case each.

🎥  Gov. Kelly: No more COVID-19-free counties in Kansas

WASHINGTON (AP) — President Donald Trump on Sunday announced emergency authorization to treat COVID-19 patients with convalescent plasma — a move he called “a breakthrough,” one of his top health officials called “promising” and other health experts said needs more study before it’s celebrated.

The announcement came after White House officials complained there were politically motivated delays by the Food and Drug Administration in approving a vaccine and therapeutics for the disease that has upended Trump’s reelection chances.

On the eve of the Republican National Convention, Trump put himself at the center of the FDA’s announcement of the authorization at a news conference Sunday evening. The authorization makes it easier for some patients to obtain the treatment but is not the same as full FDA approval.

The blood plasma, taken from patients who have recovered from the coronavirus and rich in antibodies, may provide benefits to those battling the disease. But the evidence so far has not been conclusive about whether it works, when to administer it and what dose is needed.

In a letter describing the emergency authorization, the chief scientist for the FDA, Denise Hinton, said: “COVID-19 convalescent plasma should not be considered a new standard of care for the treatment of patients with COVID-19. Additional data will be forthcoming from other analyses and ongoing, well-controlled clinical trials in the coming months.”

But Trump had made clear to aides that he was eager to showcase good news in the battle against the virus, and the timing allowed him to head into his convention with momentum. He and aides billed it as a “major” development and used the White House briefing room to make the announcement.

Trump also displayed some rare discipline in the evening news conference, sticking to his talking points, deferring to the head of the FDA, Stephen Hahn, and only taking three questions from reporters.

The White House had grown agitated with the pace of the plasma approval. The accusations of an FDA slowdown, which were presented without evidence, were just the latest assault from Trump’s team on what he refers to as the “deep state” bureaucracy. White House chief of staff Mark Meadows did not deal in specifics, but said that “we’ve looked at a number of people that are not being as diligent as they should be in terms of getting to the bottom of it.”

“This president is about cutting red tape,” Meadows said in an interview Sunday on “This Week” on ABC. “He had to make sure that they felt the heat. If they don’t see the light, they need to feel the heat because the American people are suffering.”

During Sunday’s 18-minute press conference, Trump said he thought there had been a “logjam” at the FDA over granting the emergency authorization. He alleged there are people at the FDA “that can see things being held up ... and that’s for political reasons.”

Dr. Joshua Sharfstein said the statement, and Hahn’s silence while Trump said it, “was disgraceful.”

“The FDA commissioner basically allowed the president to mischaracterize the decision and attack the integrity of FDA employees. I was horrified,” said Sharfstein, a vice dean at John Hopkins University’s school of public health who was a top FDA official during the Obama administration.

“This is a promising therapy that has not been fully established,” he said

The push on Sunday came a day after Trump tweeted sharp criticism on the process to treat the virus, which has killed more than 175,000 Americans and imperiled his reelection chances. The White House has sunk vast resources into an expedited process to develop a vaccine, and Trump aides have been banking on it being an “October surprise” that could help the president make up ground in the polls.

“The deep state, or whoever, over at the FDA is making it very difficult for drug companies to get people in order to test the vaccines and therapeutics,” Trump tweeted. “Obviously, they are hoping to delay the answer until after November 3rd. Must focus on speed, and saving lives!”

Earlier this month, Mayo Clinic researchers reported a strong hint that blood plasma from COVID-19 survivors helps other infected patients recover. But it wasn’t considered proof.

More than 70,000 patients in the U.S. have been given convalescent plasma, a century-old approach to fend off flu and measles before vaccines. It’s a go-to tactic when new diseases come along, and history suggests it works against some, but not all, infections.

The Mayo Clinic reported preliminary data from 35,000 coronavirus patients treated with plasma, and said there were fewer deaths among people given plasma within three days of diagnosis, and also among those given plasma containing the highest levels of virus-fighting antibodies.

But it wasn’t a formal study. The patients were treated in different ways in hospitals around the country as part of an FDA program designed to speed access to the experimental therapy. That “expanded access” program tracks what happens to the recipients, but it cannot prove the plasma — and not other care they received — was the real reason for improvement.

Administration officials, in a call with reporters Sunday, discussed a benefit for patients who were within three days of admission to a hospital and were not on a respirator, and were given ‘high-titer’ convalescent plasma containing higher concentrations of antibodies. They were then compared to similar patients who were given lower-titer plasma. The findings suggest deaths were 35% lower in the high-titer group.

There’s been little data on how effective it is or whether it must be administered fairly early in an illness to make a significant difference, said Dr. William Schaffner, an infectious diseases expert at Vanderbilt University.

Aiming to ward off a possible a run on convalescent plasma after the announcement, government officials have been working to obtain plasma and to team with corporate partners and nonprofit organizations to generate interest among previously infected patients to donate.

Hahn, who called the development “promising,” said Trump did not speak to him about the timing of the announcement. He said “this has been in the works for several weeks.”

But some health experts were skeptical. Benjamin Corb, of the American Society for Biochemistry and Molecular Biology, called it “conspicuous timing.”

“President Trump is once again putting his political goals ahead of the health and well-being of the American public,” Corb said.

Rigorous studies are under way around the country, comparing similar patients randomly assigned to get plasma or a dummy infusion in addition to regular care. But those studies have been difficult to finish as the virus waxes and wanes in different cities. Also, some patients have requested plasma rather than agreeing to a study that might give them a placebo instead.

Former FDA commissioner Dr. Scott Gottlieb dismissed the suggestion of a slowdown.

“I firmly reject the idea they would slow-walk anything or accelerate anything based on any political consideration or any consideration other than what is best for the public health and a real sense of mission to patients,” Gottlieb told CBS’s “Face the Nation.”

Trump, in news conferences, “has made all kinds of therapeutic suggestions” that have not proven to be supported by science — and are even dangerous, Schaffner said. That includes statements about the possible value of treating COVID-19 patients with ultraviolet light and disinfectant. Trump reportedly also recently became enthusiastic about oleandrin, a plant extract derived from a toxic shrub that scientists immediately warned against.

But the president is perhaps best known for his early and ardent embrace of the malaria drugs hydroxychloroquine and chloroquine.

Earlier this month, Hahn emphasized that routine evaluation procedures will remain in place to evaluate COVID vaccine candidates.

“I think this administration has put more pressure on the Food and Drug Administration than I can remember” ever happening in the past, Schaffner said.

“Everybody is just a little bit nervous,” he said.

WASHINGTON (AP) — President Donald Trump announced Sunday the emergency authorization of convalescent plasma for COVID-19 patients, in a move he called “a breakthrough,” one of his top health officials called “promising,” and other health experts said needs more study before it’s celebrated.

The announcement came after days of White House officials suggesting there were politically motivated delays by the Food and Drug Administration in approving a vaccine and therapeutics for the disease that has upended Trump’s reelection chances.

On the eve of the Republican National Convention, Trump put himself at the center of the FDA’s announcement of the authorization — it makes it easier for some patients to obtain the treatment — in a news conference Sunday evening.

The blood plasma, taken from patients who have recovered from the coronavirus and rich in antibodies, may provide benefits to those battling with the disease. But the evidence so far has not been conclusive about whether it works, when to administer it and what dose is needed.

In a letter describing the emergency authorization, the chief scientist for the FDA, Denise Hinton, noted: “COVID-19 convalescent plasma should not be considered a new standard of care for the treatment of patients with COVID-19. Additional data will be forthcoming from other analyses and ongoing, well-controlled clinical trials in the coming months.”

An emergency use authorization is not the same as full FDA approval.

In the authorization letter, FDA officials emphasized convalescent plasma is still under investigation. “COVID-19 convalescent plasma should not be considered a new standard of care for the treatment of patients with COVID-19. Additional data will be forthcoming from other analyses and ongoing, well-controlled clinical trials in the coming months,” it said.

But Trump had made clear to aides that he was eager for a piece of good news on the battle of the pandemic, and the timing allowed him to head into the convention with momentum. He and aides billed it as a “major” development and utilized the White House briefing room to make the announcement.

The White House had grown agitated with the pace of the plasma approval, but the accusations of a slowdown, which were presented without evidence, were just the latest assault from Trump’s team on the “deep state” bureaucracy. White House chief of staff Mark Meadows did not deal in specifics, but said that “we’ve looked at a number of people that are not being as diligent as they should be in terms of getting to the bottom of it.”

There’s no solid evidence yet that it fights the coronavirus and, if so, how best to use it.

Hahn, who called the development “promising,” said Trump did not speak to him about the timing of the announcement, which comes just before a pivotal week for the president’s reelection chances. Hahn said “this has been in the works for several weeks” and came after a data validation for which the agency had been waiting.

Rigorous studies underway around the country are designed to get that proof, by comparing similar patients randomly assigned to get plasma or a dummy infusion in addition to regular care. But those studies have been difficult to finish as the virus waxes and wanes in different cities. Also, some patients have requested plasma rather than agreeing to a study that might give them a placebo instead.

Hundreds of drugs are currently being developed as possible treatments against the coronavirus infection, taking a range of approaches.

<figure>
 <img src="https://media.eaglewebservices.com/public/2020/8/1598222952199.png" alt="President Trump took only 3 questions during the Sunday evening press conference-photo courtesy White House" />
 <figcaption>President Trump took only 3 questions during the Sunday evening press conference-photo courtesy White House</figcaption>
 </figure>WASHINGTON (AP) — President Donald Trump on Sunday announced emergency authorization to treat COVID-19 patients with convalescent plasma — a move he called “a breakthrough,” one of his top health officials called “promising” and other health experts said needs more study before it’s celebrated.The announcement came after White House officials complained there were politically motivated delays by the Food and Drug Administration in approving a vaccine and therapeutics for the disease that has upended Trump’s reelection chances.On the eve of the Republican National Convention, Trump put himself at the center of the FDA’s announcement of the authorization at a news conference Sunday evening. The authorization makes it easier for some patients to obtain the treatment but is not the same as full FDA approval.The blood plasma, taken from patients who have recovered from the coronavirus and rich in antibodies, may provide benefits to those battling the disease. But the evidence so far has not been conclusive about whether it works, when to administer it and what dose is needed.In a letter describing the emergency authorization, the chief scientist for the FDA, Denise Hinton, said: “COVID-19 convalescent plasma should not be considered a new standard of care for the treatment of patients with COVID-19. Additional data will be forthcoming from other analyses and ongoing, well-controlled clinical trials in the coming months.”But Trump had made clear to aides that he was eager to showcase good news in the battle against the virus, and the timing allowed him to head into his convention with momentum. He and aides billed it as a “major” development and used the White House briefing room to make the announcement.Trump also displayed some rare discipline in the evening news conference, sticking to his talking points, deferring to the head of the FDA, Stephen Hahn, and only taking three questions from reporters.The White House had grown agitated with the pace of the plasma approval. The accusations of an FDA slowdown, which were presented without evidence, were just the latest assault from Trump’s team on what he refers to as the “deep state” bureaucracy. White House chief of staff Mark Meadows did not deal in specifics, but said that “we’ve looked at a number of people that are not being as diligent as they should be in terms of getting to the bottom of it.”“This president is about cutting red tape,” Meadows said in an interview Sunday on “This Week” on ABC. “He had to make sure that they felt the heat. If they don’t see the light, they need to feel the heat because the American people are suffering.”<figure>
 <img src="https://media.eaglewebservices.com/public/2020/8/1598222686256.png" alt="President Donald Trump accompanied by Food and Drug Administration Commissioner Dr. Stephen Hahn, center and HHS Secretary Alex Azar during a media briefing Sunday -photo Courtesy White House." />
 <figcaption>President Donald Trump accompanied by Food and Drug Administration Commissioner Dr. Stephen Hahn, center and HHS Secretary Alex Azar during a media briefing Sunday -photo Courtesy White House.</figcaption>
 </figure>During Sunday’s 18-minute press conference, Trump said he thought there had been a “logjam” at the FDA over granting the emergency authorization. He alleged there are people at the FDA “that can see things being held up ... and that’s for political reasons.”Dr. Joshua Sharfstein said the statement, and Hahn’s silence while Trump said it, “was disgraceful.”“The FDA commissioner basically allowed the president to mischaracterize the decision and attack the integrity of FDA employees. I was horrified,” said Sharfstein, a vice dean at John Hopkins University’s school of public health who was a top FDA official during the Obama administration.“This is a promising therapy that has not been fully established,” he saidThe push on Sunday came a day after Trump tweeted sharp criticism on the process to treat the virus, which has killed more than 175,000 Americans and imperiled his reelection chances. The White House has sunk vast resources into an expedited process to develop a vaccine, and Trump aides have been banking on it being an “October surprise” that could help the president make up ground in the polls.“The deep state, or whoever, over at the FDA is making it very difficult for drug companies to get people in order to test the vaccines and therapeutics,” Trump tweeted. “Obviously, they are hoping to delay the answer until after November 3rd. Must focus on speed, and saving lives!”Earlier this month, Mayo Clinic researchers reported a strong hint that blood plasma from COVID-19 survivors helps other infected patients recover. But it wasn’t considered proof.More than 70,000 patients in the U.S. have been given convalescent plasma, a century-old approach to fend off flu and measles before vaccines. It’s a go-to tactic when new diseases come along, and history suggests it works against some, but not all, infections.The Mayo Clinic reported preliminary data from 35,000 coronavirus patients treated with plasma, and said there were fewer deaths among people given plasma within three days of diagnosis, and also among those given plasma containing the highest levels of virus-fighting antibodies.But it wasn’t a formal study. The patients were treated in different ways in hospitals around the country as part of an FDA program designed to speed access to the experimental therapy. That “expanded access” program tracks what happens to the recipients, but it cannot prove the plasma — and not other care they received — was the real reason for improvement.Administration officials, in a call with reporters Sunday, discussed a benefit for patients who were within three days of admission to a hospital and were not on a respirator, and were given ‘high-titer’ convalescent plasma containing higher concentrations of antibodies. They were then compared to similar patients who were given lower-titer plasma. The findings suggest deaths were 35% lower in the high-titer group.There’s been little data on how effective it is or whether it must be administered fairly early in an illness to make a significant difference, said Dr. William Schaffner, an infectious diseases expert at Vanderbilt University.Aiming to ward off a possible a run on convalescent plasma after the announcement, government officials have been working to obtain plasma and to team with corporate partners and nonprofit organizations to generate interest among previously infected patients to donate.Hahn, who called the development “promising,” said Trump did not speak to him about the timing of the announcement. He said “this has been in the works for several weeks.”But some health experts were skeptical. Benjamin Corb, of the American Society for Biochemistry and Molecular Biology, called it “conspicuous timing.”“President Trump is once again putting his political goals ahead of the health and well-being of the American public,” Corb said.Rigorous studies are under way around the country, comparing similar patients randomly assigned to get plasma or a dummy infusion in addition to regular care. But those studies have been difficult to finish as the virus waxes and wanes in different cities. Also, some patients have requested plasma rather than agreeing to a study that might give them a placebo instead.Former FDA commissioner Dr. Scott Gottlieb dismissed the suggestion of a slowdown.“I firmly reject the idea they would slow-walk anything or accelerate anything based on any political consideration or any consideration other than what is best for the public health and a real sense of mission to patients,” Gottlieb told CBS’s “Face the Nation.”<figure>
 <img src="https://media.eaglewebservices.com/public/2020/8/1598218807664.png" alt="President Trump during the Sunday evening news conference -photo courtesy White House" />
 <figcaption>President Trump during the Sunday evening news conference -photo courtesy White House</figcaption>
 </figure>Trump, in news conferences, “has made all kinds of therapeutic suggestions” that have not proven to be supported by science — and are even dangerous, Schaffner said. That includes statements about the possible value of treating COVID-19 patients with ultraviolet light and disinfectant. Trump reportedly also recently became enthusiastic about oleandrin, a plant extract derived from a toxic shrub that scientists immediately warned against.But the president is perhaps best known for his early and ardent embrace of the malaria drugs hydroxychloroquine and chloroquine.Earlier this month, Hahn emphasized that routine evaluation procedures will remain in place to evaluate COVID vaccine candidates.“I think this administration has put more pressure on the Food and Drug Administration than I can remember” ever happening in the past, Schaffner said.“Everybody is just a little bit nervous,” he said.-----------WASHINGTON (AP) — President Donald Trump announced Sunday the emergency authorization of convalescent plasma for COVID-19 patients, in a move he called “a breakthrough,” one of his top health officials called “promising,” and other health experts said needs more study before it’s celebrated.The announcement came after days of White House officials suggesting there were politically motivated delays by the Food and Drug Administration in approving a vaccine and therapeutics for the disease that has upended Trump’s reelection chances.On the eve of the Republican National Convention, Trump put himself at the center of the FDA’s announcement of the authorization — it makes it easier for some patients to obtain the treatment — in a news conference Sunday evening.The blood plasma, taken from patients who have recovered from the coronavirus and rich in antibodies, may provide benefits to those battling with the disease. But the evidence so far has not been conclusive about whether it works, when to administer it and what dose is needed.In a letter describing the emergency authorization, the chief scientist for the FDA, Denise Hinton, noted: “COVID-19 convalescent plasma should not be considered a new standard of care for the treatment of patients with COVID-19. Additional data will be forthcoming from other analyses and ongoing, well-controlled clinical trials in the coming months.”An emergency use authorization is not the same as full FDA approval.In the authorization letter, FDA officials emphasized convalescent plasma is still under investigation. “COVID-19 convalescent plasma should not be considered a new standard of care for the treatment of patients with COVID-19. Additional data will be forthcoming from other analyses and ongoing, well-controlled clinical trials in the coming months,” it said.But Trump had made clear to aides that he was eager for a piece of good news on the battle of the pandemic, and the timing allowed him to head into the convention with momentum. He and aides billed it as a “major” development and utilized the White House briefing room to make the announcement.Trump also displayed some rare discipline in the evening news conference, sticking to his talking points, deferring to the head of the FDA, Stephen Hahn, and only taking three questions from reporters.The White House had grown agitated with the pace of the plasma approval, but the accusations of a slowdown, which were presented without evidence, were just the latest assault from Trump’s team on the “deep state” bureaucracy. White House chief of staff Mark Meadows did not deal in specifics, but said that “we’ve looked at a number of people that are not being as diligent as they should be in terms of getting to the bottom of it.”“This president is about cutting red tape,” Meadows said in an interview Sunday on “This Week” on ABC. “He had to make sure that they felt the heat. If they don’t see the light, they need to feel the heat because the American people are suffering.”The push on Sunday came a day after Trump tweeted sharp criticism on the process to treat the virus, which has killed more than 175,000 Americans and imperiled his reelection chances. The White House has sunk vast resources into an expedited process to develop a vaccine, and Trump aides have been banking on it being an “October surprise” that could help the president make up ground in the polls.“The deep state, or whoever, over at the FDA is making it very difficult for drug companies to get people in order to test the vaccines and therapeutics,” Trump tweeted. “Obviously, they are hoping to delay the answer until after November 3rd. Must focus on speed, and saving lives!”Earlier this month, Mayo Clinic researchers reported a strong hint that blood plasma from COVID-19 survivors helps other infected patients recover. But it wasn’t considered proof.More than 70,000 patients in the U.S. have been given convalescent plasma, a century-old approach to fend off flu and measles before vaccines. It’s a go-to tactic when new diseases come along, and history suggests it works against some, but not all, infections.There’s no solid evidence yet that it fights the coronavirus and, if so, how best to use it.The Mayo Clinic reported preliminary data from 35,000 coronavirus patients treated with plasma, and said there were fewer deaths among people given plasma within three days of diagnosis, and also among those given plasma containing the highest levels of virus-fighting antibodies.But it wasn’t a formal study. The patients were treated in different ways in hospitals around the country as part of an FDA program designed to speed access to the experimental therapy. That “expanded access” program tracks what happens to the recipients, but it cannot prove the plasma — and not other care they received — was the real reason for improvement.Administration officials, in a call with reporters Sunday, discussed a benefit for patients who were within three days of admission to a hospital and were not on a respirator, and were given ‘high-titer’ convalescent plasma containing higher concentrations of antibodies. They were then compared to similar patients who were given lower-titer plasma. The findings suggest deaths were 35% lower in the high-titer group.There’s been little data on how effective it is or whether it must be administered fairly early in an illness to make a significant difference, said Dr. William Schaffner, an infectious diseases expert at Vanderbilt University.Aiming to ward off a possible a run on convalescent plasma after the announcement, government officials have been working to obtain plasma and to team with corporate partners and nonprofit organizations to generate interest among previously infected patients to donate.Hahn, who called the development “promising,” said Trump did not speak to him about the timing of the announcement, which comes just before a pivotal week for the president’s reelection chances. Hahn said “this has been in the works for several weeks” and came after a data validation for which the agency had been waiting.But some health experts were skeptical. Benjamin Corb, of the American Society for Biochemistry and Molecular Biology, called it “conspicuous timing.”“President Trump is once again putting his political goals ahead of the health and well-being of the American public,” Corb said.Rigorous studies underway around the country are designed to get that proof, by comparing similar patients randomly assigned to get plasma or a dummy infusion in addition to regular care. But those studies have been difficult to finish as the virus waxes and wanes in different cities. Also, some patients have requested plasma rather than agreeing to a study that might give them a placebo instead.Former FDA commissioner Dr. Scott Gottlieb dismissed the suggestion of a slowdown.ADVERTISEMENT“I firmly reject the idea they would slow-walk anything or accelerate anything based on any political consideration or any consideration other than what is best for the public health and a real sense of mission to patients,” Gottlieb told CBS’s “Face the Nation.”Hundreds of drugs are currently being developed as possible treatments against the coronavirus infection, taking a range of approaches.Trump, in news conferences, “has made all kinds of therapeutic suggestions” that have not proven to be supported by science — and are even dangerous, Schaffner said. That includes statements about the possible value of treating COVID-19 patients with ultraviolet light and disinfectant. Trump reportedly also recently became enthusiastic about oleandrin, a plant extract derived from a toxic shrub that scientists immediately warned against.But the president is perhaps best known for his early and ardent embrace of the malaria drugs hydroxychloroquine and chloroquine.Earlier this month, Hahn emphasized that routine evaluation procedures will remain in place to evaluate COVID vaccine candidates.“I think this administration has put more pressure on the Food and Drug Administration than I can remember” ever happening in the past, Schaffner said.“Everybody is just a little bit nervous,” he said.----

Trump: Plasma treatment for COVID-19 a breakthrough

WASHINGTON (AP) — A widely used coronavirus test is under scrutiny this week after federal health officials warned that it could deliver inaccurate results if laboratory technicians don’t follow the the latest updates from the manufacturer.

The Food and Drug Administration’s warning over Thermo Fisher’s TaqPath test underscores the complexity of COVID-19 tests and how easily they can be skewed by faulty processing and equipment.

The FDA action follows a report last month by Connecticut public health officials that the test resulted in at least 90 people receiving false positive results for the coronavirus.

Thermo Fisher’s test is one of the standard tools used to screen for COVID-19, run on large, automated machines found in many U.S. hospitals and laboratories. The FDA flagged two separate issues that could potentially result in false results: the chemical mixing process and computer software that runs on the company’s machine. Thermo Fisher has provided new instructions for mixing. And a software update fixes the second problem, the FDA said.

For all positive results, FDA said labs should review the instrument settings.

Thermo Fisher said in a statement that its data shows the issues are rare and most users get accurate results by following company directions.

No test is 100% accurate and all medical tests are expected to deliver a certain small portion of false results. Less is known about the accuracy of COVID-19 tests because of how quickly they were rushed through the regulatory process because of the pandemic.

Thermo Fisher’s test uses molecular technology that is considered the gold standard for detecting the COVID-19 virus and other viruses. The test uses chemicals to extract the genetic material of the virus from a nasal swab, then amplifies it many times until it is detectable with a computer.

Thermo Fisher’s test was among the first granted emergency use by the FDA in mid-March. Like other companies, it got the OK based on laboratory experiments it submitted to regulators. The test successfully detected coronavirus in 60 lab-made samples of the virus, and successfully ruled out the virus in 60 samples that didn’t contain the virus. That was sufficient to meet FDA requirements..

However,&nbsp;<a href="https://apnews.com/38967d1644ef374d1bcbc7806b383b8e">experts have warned</a>&nbsp;that these laboratory measures are very different from the large patient studies that assess the real-world performance of a test. Those studies can reveal factors that can skew results, such as faulty samples or incorrect processing .

The biggest concern during infectious disease outbreaks is usually avoiding false negatives, or when the test fails to catch people who are actually infected. That can result in some people unknowingly spreading the virus.

But Dr. Albert Ko of Yale’s School of Public Health noted that false positives can also create problems, particularly in places like nursing homes and prisons where people are grouped together based on test results.

“You may wind up putting someone who hasn’t been infected together with people who may be infected and are contagious,” Ko said.

Test results can be affected by a variety of factors, including the type of test used, the quality of the sample and when it was taken during the course of any infection.

WASHINGTON (AP) — A widely used coronavirus test is under scrutiny this week after federal health officials warned that it could deliver inaccurate results if laboratory technicians don’t follow the the latest updates from the manufacturer.The Food and Drug Administration’s warning over Thermo Fisher’s TaqPath test underscores the complexity of COVID-19 tests and how easily they can be skewed by faulty processing and equipment.The FDA action follows a report last month by Connecticut public health officials that the test resulted in at least 90 people receiving false positive results for the coronavirus.WHAT HAPPENED WITH THE TEST?Thermo Fisher’s test is one of the standard tools used to screen for COVID-19, run on large, automated machines found in many U.S. hospitals and laboratories. The FDA flagged two separate issues that could potentially result in false results: the chemical mixing process and computer software that runs on the company’s machine. Thermo Fisher has provided new instructions for mixing. And a software update fixes the second problem, the FDA said.For all positive results, FDA said labs should review the instrument settings.Thermo Fisher said in a statement that its data shows the issues are rare and most users get accurate results by following company directions.HOW ACCURATE ARE COVID-19 TESTS?No test is 100% accurate and all medical tests are expected to deliver a certain small portion of false results. Less is known about the accuracy of COVID-19 tests because of how quickly they were rushed through the regulatory process because of the pandemic.Thermo Fisher’s test uses molecular technology that is considered the gold standard for detecting the COVID-19 virus and other viruses. The test uses chemicals to extract the genetic material of the virus from a nasal swab, then amplifies it many times until it is detectable with a computer.Thermo Fisher’s test was among the first granted emergency use by the FDA in mid-March. Like other companies, it got the OK based on laboratory experiments it submitted to regulators. The test successfully detected coronavirus in 60 lab-made samples of the virus, and successfully ruled out the virus in 60 samples that didn’t contain the virus. That was sufficient to meet FDA requirements..However,&nbsp;<a href="https://apnews.com/38967d1644ef374d1bcbc7806b383b8e">experts have warned</a>&nbsp;that these laboratory measures are very different from the large patient studies that assess the real-world performance of a test. Those studies can reveal factors that can skew results, such as faulty samples or incorrect processing .HOW SIGNIFICANT ARE FALSE RESULTS?The biggest concern during infectious disease outbreaks is usually avoiding false negatives, or when the test fails to catch people who are actually infected. That can result in some people unknowingly spreading the virus.But Dr. Albert Ko of Yale’s School of Public Health noted that false positives can also create problems, particularly in places like nursing homes and prisons where people are grouped together based on test results.“You may wind up putting someone who hasn’t been infected together with people who may be infected and are contagious,” Ko said.Test results can be affected by a variety of factors, including the type of test used, the quality of the sample and when it was taken during the course of any infection.___

Many steps needed for accurate COVID-19 test results

<figure>
 <img src="https://media.eaglewebservices.com/public/2020/8/1598043239410.png" alt="Barton County reported 12 new cases of COVID-19 as of 4 p.m. Aug. 21, 2020." />
 <figcaption>Barton County reported 12 new cases of COVID-19 as of 4 p.m. Aug. 21, 2020.</figcaption>
 </figure>

Barton County coronavirus update: 76 active cases

It is with great sadness that we announce that Barton County has confirmed the fourth known COVID-19 related death of a Barton County resident.

Our heartfelt sympathy goes to the family, friends, and caregivers.

From Barton County…It is with great sadness that we announce that Barton County has confirmed the fourth known COVID-19 related death of a Barton County resident.Our heartfelt sympathy goes to the family, friends, and caregivers.

Barton County confirms COVID-19 related death

<figure>
 <img src="https://media.eaglewebservices.com/public/2020/8/1597938161300.png" alt="Barton County reported 9 new cases of COVID-19 as of 10:30 a.m. Aug. 20, 2020." />
 <figcaption>Barton County reported 9 new cases of COVID-19 as of 10:30 a.m. Aug. 20, 2020.</figcaption>
 </figure>

Barton County coronavirus update: 9 new cases

TOPEKA, Kan. (AP) — The Kansas death toll from the coronavirus pandemic rose to 411 on Wednesday as public health officials reported six more deaths.

The state Department of Health and Environment also reported on its website that Kansas had another 723 confirmed and probable cases since Monday, an increase of 2%, for a total of 35,890.

The actual number of cases is thought to be far higher because people can be infected without feeling ill and because of a lack of testing, particularly early in the pandemic.

Kansas has had 441 coronavirus clusters since the pandemic began, with 209 deaths at long-term care facilities, the health department said. Clusters at meatpacking plants accounted for 19 deaths and religious gatherings accounted for 12 deaths.

Health officials reported five clusters at Kansas colleges and universities associated with 57 coronavirus cases, with no hospitalizations or deaths associated with them.

Daycare facilities and schools were associated with 16 clusters associated with 78 cases, including one which required hospitalization.

Shawnee Mission, among the state’s largest school districts, plans to start classes online and suspend sports. But a neighboring school district is holding off on making a call as some parents urge them to reopen.

TOPEKA, Kan. (AP) — The Kansas death toll from the coronavirus pandemic rose to 411 on Wednesday as public health officials reported six more deaths.<div><iframe src="https://www.facebook.com/plugins/video.php?href=https%3A%2F%2Fwww.facebook.com%2FKDHEnews%2Fvideos%2F2680082192274634%2F&show_text=0&width=560" width="560" height="315" style="border:none;overflow:hidden" scrolling="no" frameborder="0" allowTransparency="true" allowFullScreen="true"></iframe></div>The state Department of Health and Environment also reported on its website that Kansas had another 723 confirmed and probable cases since Monday, an increase of 2%, for a total of 35,890.The actual number of cases is thought to be far higher because people can be infected without feeling ill and because of a lack of testing, particularly early in the pandemic.Kansas has had 441 coronavirus clusters since the pandemic began, with 209 deaths at long-term care facilities, the health department said. Clusters at meatpacking plants accounted for 19 deaths and religious gatherings accounted for 12 deaths.Health officials reported five clusters at Kansas colleges and universities associated with 57 coronavirus cases, with no hospitalizations or deaths associated with them.Daycare facilities and schools were associated with 16 clusters associated with 78 cases, including one which required hospitalization.Shawnee Mission, among the state’s largest school districts, plans to start classes online and suspend sports. But a neighboring school district is holding off on making a call as some parents urge them to reopen.--------

🎥  Pandemic death toll rises with 6 new deaths in Kansas

Press release from Barton County...Unfortunately, the vague description can’t go into further detail or it would violate HIPAA guidelines.

Following KDHE guidance, Barton County provides the following information:

The Barton County Health Department has identified multiple positive cases of COVID-19 associated with a large birthday party gathering involving high school age young adults at a private residence in Great Bend on Saturday, August 8th. Individuals who attended this gathering may have been exposed to the novel coronavirus (COVID-19).

The Barton County Health Department encourages those who were at the above gathering during the identified day to monitor themselves for symptoms of COVID-19 for 14 days. Symptoms include fever, cough, chills, muscle pain, sore throat, new loss of taste or smell, fatigue, diarrhea, and/or shortness of breath/difficulty breathing. 

If symptoms develop, please stay home, and contact your health care provider for guidance on testing. In an emergency, please call 911and notify first responders that you were potentially exposed to COVID-19 and, if possible, wear a cloth face mask before they arrive.

<figure>
 <img src="https://media.eaglewebservices.com/public/2020/4/1586533807157.jpeg" alt="" />
 <figcaption></figcaption>
 </figure>Press release from Barton County...Unfortunately, the vague description can’t go into further detail or it would violate HIPAA guidelines.Following KDHE guidance, Barton County provides the following information:The Barton County Health Department has identified multiple positive cases of COVID-19 associated with a large birthday party gathering involving high school age young adults at a private residence in Great Bend on Saturday, August 8th. Individuals who attended this gathering may have been exposed to the novel coronavirus (COVID-19).The Barton County Health Department encourages those who were at the above gathering during the identified day to monitor themselves for symptoms of COVID-19 for 14 days. Symptoms include fever, cough, chills, muscle pain, sore throat, new loss of taste or smell, fatigue, diarrhea, and/or shortness of breath/difficulty breathing. If symptoms develop, please stay home, and contact your health care provider for guidance on testing. In an emergency, please call 911and notify first responders that you were potentially exposed to COVID-19 and, if possible, wear a cloth face mask before they arrive.

Coronavirus Update